Rapid conversion of myelin-associated glycoprotein to a soluble derivative in primates

Brain Research

Volumn 741, Issue 1-2, 1996, Pages 27-31

  Möller, Johanna R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

myelin; myelin basic protein; myelin associated glycoprotein; primate; protease

Indexed keywords

MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; PROTEINASE;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DEMYELINATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAMMAL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CATS; CATTLE; CHIROPTERA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GUINEA PIGS; HUMANS; INFANT, NEWBORN; MICE; MYELIN-ASSOCIATED GLYCOPROTEIN; PRIMATES; RABBITS; RATS; SHEEP; SPECIES SPECIFICITY;

EID: 0030602043     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00882-7     Document Type: Article

References (42)

1. [1] Alvord Jr., E.C., Rose, L.M. and Richards T.L., Chronic experimental allergic encephalomyelitis as a model of multiple sclerosis. In R.E. Martenson (Ed.), Myelin: Biology and Chemistry, Chap. 30, CRC Press, Boca Raton, 1992, pp. 849-891.
2. [2] Arquint, M., Roder, J., Chia, L., Down, J., Wilkerson, D., Bayley, H., Braun, P. and Dunn, R., Molecular cloning and the primary structure of the myelin-associated glycoprotein, Proc. Natl. Acad. Sci. USA, 84 (1987) 600-604.
3. 2+-activated neutral proteinase associated with purified myelin of rat CNS, J. Neurochem., 45 (1985) 581-588.
4. [4] Berlet, H.H., Degradation of myelin proteins by proteinases. In R.E. Martenson (Ed.), Myelin: Biology and Chemistry, Chap. 18, CRC Press, Boca Raton, 1992, pp. 599-631.
5. [5] Chakrabarti, A.K. and Banik, N.L., Purification of calcium-activated neutral proteinase (CANP) from purified myelin of bovine brain white matter, Neurochem. Res., 13 (1988) 127-134.
6. [6] Chakrabarti, A.K., Quarles, R.H. and Möller, J.R., Purification of m-calpain from human brain myelin and its role in the degradation of MAG, Trans. Am. Soc. Neurochem., 24 (1993) 131 (abstract).
7. [7] Cohen, S.R., Brooks, B.R., Hemdon, R.M. and McKhann, G.M., A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid, Ann. Neurol., 8 (1980) 25-31.
8. [8] Dobersen, M.J., Hammer, J.A., Noronha, A.B., MacIntosh, T.D., Trapp, B.D., Brady, R.O. and Quarles, R.H., Generation and characterization of mouse monoclonal antibodies to the myelin-associated glycoprotein (MAG), Neurochem. Res., 10 (1985) 499-513.
9. [9] Fairbanks, G., Steck, T.L. and Wallach, D.F.H., Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane, Biochemistry, 10 (1971) 2606-2617.
10. [10] Fujita, N., Sato, S., Kurihara, T., Kuwano, R., Sakimura, K., Inuzuka, T., Takahashi, Y. and Miyatake, T., cDNA cloning of mouse myelin-associated glycoprotein: a novel alternative splicing pattern, Biochem. Biophys. Res. Commun., 165 (1989) 1162-1169.
11. [11] Gendelman, H.E., Pezeshkpour, G.H., Pressman, N.J., Wolinsky, J.S., Quarles, R.H., Dobersen, MJ., Trapp, B.D., Kitt, C.A., Aksamit, A, and Johnson R.T., A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases, Ann. Neurol., 18 (1985) 324-328.
12. [12] Itoyama, Y., Sternberger, N.H., Webster, H. deF., Quarles, R.H., Cohen, S.R. and Richardson Jr., E.P., Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions, Ann. Neurol., 7 (1980) 167-177.
13. [13] Itoyama, Y. and Webster, H. de F., Immunocytochemical study of myelin-associated glycoprotein (MAG) and basic protein (BP) in acute experimental allergic encephalomyelitis (EAE), J. Neuroimmunol., 3 (1982)351-364.
14. [14] Johnson, D., Sato, S., Quarles, R.H., Inuzuka, T., Brady, R.O. and Tourtellotte, W.W., Quantitation of the myelin-associated glycoprotein in human nervous tissue from controls and multiple sclerosis patients, J. Neurochem., 46 (1986) 1086-1093.
15. [15] Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227 (1970) 680-685.
16. [16] Lai, C., Brow, M.A., Nave, K.A., Noronha, A.B., Quarles, R.H., Bloom, F.E., Milner, R.J. and Sutcliffe, J.G., Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing, Proc. Natl. Acad. Sci. USA. 84 (1987) 4337-4341.
17. [17] Lowry, O.H., Rosebrough, N.J., Farr. A.L. and Randall, R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
18. [18] Möller, J.R., Species variation in the proteolytic cleavage of MAG to dMAG, Trans. Am. Soc. Neurochem., 24 (1993) 255 (abstract).
19. [19] Möller, J.R., Lazzarini, R.A. and Quarles, R.H., Isolation and partial characterization of a cDNA for human myelin-associated glycoprotein (MAG), Soc. Neurosci. Abstr., 14, (1988) 785 (abstract).
20. [20] Möller, J.R., Yanagisawa, K., Brady, R.O., Tourtellotte, W.W. and Quarles, R.H., Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis, Ann. Neurol., 22 (1987) 469-474.
21. [21] Morell, P., Quarles, R.H. and Norton, W.T., Myelin formation, structure, and biochemistry. Ch. 6. In G.J. Siegel et al. (Ed.), Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 5th edn, Raven Press, New York, 1994. pp. 771-792.
22. [22] Norton, W.T. and Poduslo, S.E., Myelination in rat brain: method of myelin isolation, J. Neurochem., 21 (1973) 749-759.
23. [23] Prineas, J.W., Kwon, E.E., Sternberger, N.H. and Lennon, V.A., The distribution of myelin-associated glycoprotein and myelin basic protein in actively demyelinating multiple sclerosis lesions, J. Neuroimmunol., 6 (1984) 251-264.
24. [24] Quarles, R.H., Coleman, D.R., Salzer, J.L. and Trapp, B.D., Myelin-associated glycoprotein: structure-function relationships and involvement in neurological diseases, Ch. 12. In R.E. Martenson (Ed.), Myelin: Biology and Chemistry, CRC Press, Boca Raton, 1992, pp. 413-448.
25. [25] Raine, C.S., Experimental allergic encephalomyelitis and experimental allergic neuritis, Ch. 16. In J.C. Koetsier (Ed.), Handbook of Clinical Neurology, Vol. 3 (47): Demyelinating Diseases, Elsevier Science, Amsterdam, (1985) 429-466.
26. [26] Salzer, J.L., Holmes, W.P. and Colman, D.R., The amino acid sequences of the myelin-associated glycoproteins: homology to the immunoglobulin gene superfamily, J. Cell Biol., 104 (1987) 957-965.
27. [27] Sasaki, T., Kikuchi, T., Yumoto, N., Yoshimura, N. and Murachi, T., Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates, J. Biol. Chem., 259 (1984) 12489-12494.
28. [28] Sato, S., Fujita, N., Kurihara, T., Kuwano, R., Sakimura, K., Takahashi, Y. and Miyatake, T., cDNA cloning and amino acid sequence for human myelin-associated glycoprotein, Biochem. Biophys. Res. Commun., 163 (1989) 1473-1480.
29. [29] Sato, S., Quarles, R.H. and Brady, R.O., Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain, J. Neurochem., 39 (1982) 97-105.
30. [30] Sato, S., Quarles, R.H., Brady, R.O. and Tourtellotte, W.W., Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis, Ann. Neurol., 15 (1984) 264-267.
31. [31] Sato. S., Yanagisawa, K. and Miyatake, T., Conversion of myelin-associated glycoprotein (MAG) to a smaller derivative by calcium activated neutral protease (CANP)-like enzyme in myelin and inhibition by E-64 analogue, Neurochem. Res., 9 (1984) 629-635.
32. [32] Spagnol, G., Williams, M., Srinivasan, J., Golier, J., Bauer, D., Lebo, R.V. and Latov, N., Molecular cloning of human myelin-associated glycoprotein, J Neurosci. Res., 24 (1989) 137-142.
33. [33] Stebbins, J.W., Jaffe, H., Fales, H.M. and Möller, J.R., Determination of the carboxy-terminus of a proteolysis product derived from myelin-associated glycoprotein (dMAG), J. Neurochem. Suppl., 66 (1996) S5B (abstract).
34. [34] Steck, A.J., Murray, N., Vandevelde, M. and Zurbriggen, A., Human monoclonal antibodies to myelin-associated glycoprotein: comparison of specificity and use for immunocytochemical localization of antigen, J. Neuroimmunol., 5 (1983) 145-156.
35. [35] Sternberger, N.H, McFarlin, D.E., Traugott, U. and Raine, C.S., Myelin basic protein and myelin-associated glycoprotein in chronic, relapsing experimental allergic encephalomyelitis, J. Neuroimmunol., 6 (1984) 217-229.
36. [36] Takahashi, K., Calpain substrate specificity, Ch. 4. In R.L. Mellgren and T. Murachi (Eds.), Intracellular Calcium-Dependent Proteolysis, CRC Press, Boca Raton, 1990, pp. 55-74.
37. [37] Towbin, H., Staehelin, T. and Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. USA, 76 (1979) 4350-4354.
38. [38] Webster, H. de F., Shii, H. and Lassmann, H., Immunocytochemical study of myelin-associated glycoprotein (MAG), basic protein (BP), and glial fibrillary acidic protein (GFAP) in chronic relapsing experimental allergic encephalomyelitis (EAE), Acta Neuropathol., 65 (1985) 177-189.
39. [39] Wekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H. and Linnington, C., Animal models, Ann. Neurol., 36 (1994) S47-S53.
40. [40] Whitaker, J.N., Lisak, R.P., Bashir, R.M., Fitch, D.H., Seyer, J.M., Krance, R., Lawrence, J.A., Chien, L.T. and O'Sullivan, P., Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders, Ann. Neurol., 7 (1980) 58-64.
41. [41] Yanagisawa. K., Quarles, R.H., Johnson, D., Brady, R.O. and Whitaker, J.N., A derivative of myelin-associated glycoprotein (dMAG) in cerebrospinal fluid of normal subjects and patients with neurological disease, Ann. Neurol., 18 (1985) 464-469.
42. [42] Yanagisawa, K., Sato, S., Amaya, N. and Miyatake, T., Degradation of myelin basic protein by calcium-activated neutral protease (CANP) in human brain and inhibition by E-64 analogue, Neurochem. Res. 8 (1983) 1285-1293.